Follow The Filings

ATRA Atara Biotherapeutics

Atara Biotherapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ATRA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ATRA insider trades
  • $5.7M bought by 2 insiders
  • $3.7M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Brian N Cherry Director
    Buy
    $1M 104,166 shares at $9.60 +167% to stake
    Traded Sep 4 Filed Sep 4
    ↗
  2. James Huang Director, +1 joint filer
    Sale
    $3.2M 313,446 shares at $10.10 24% of stake
    Traded May 7 Filed May 11
    ↗
  3. EcoR1 Capital, LLC 10% owner
    Buy
    $4.7M 507,407 shares at $9.35 +49% to stake
    Traded May 7 Filed May 11
    ↗
  4. James Huang Director, +1 joint filer
    Sale
    $489K 80,554 shares at $6.07 5.7% of stake
    Traded Jan 12 Filed Jan 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 16 sales to cover taxes, 6 stock grants, 3 share withholdings for taxes, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
8-K 3.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.